<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02787785</url>
  </required_header>
  <id_info>
    <org_study_id>MADIT S-ICD (C1834)</org_study_id>
    <nct_id>NCT02787785</nct_id>
  </id_info>
  <brief_title>Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator</brief_title>
  <acronym>MADIT S-ICD</acronym>
  <official_title>Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
  </oversight_info>
  <brief_summary>
    <textblock>
      The MADIT S-ICD trial is designed to evaluate if subjects with a prior myocardial infarction,
      diabetes mellitus and a relatively preserved ejection fraction of 36-50% will have a survival
      benefit from receiving a subcutaneous implantable cardioverter defibrillator (S-ICD) when
      compared to those receiving conventional medical therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, subjects will be randomized to receive a subcutaneous implantable cardioverter
      defibrillator or Conventional Medical Therapy (CMT). Randomization will be stratified by
      enrolling site, in a 2:1 (S-ICD:CMT) scheme. Length of follow-up for each subject will be
      dependent on the date of entry into the study, since all subjects will be followed to a
      common study termination date.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2017</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-Cause Mortality</measure>
    <time_frame>Through study completion,estimated average of 2.6 years follow-up</time_frame>
    <description>This study is event driven so there is no set end date for follow-up or analysis. Subjects will be followed until the statistical boundary is crossed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-Cause Mortality in various subgroups</measure>
    <time_frame>Through study completion,estimated average of 2.6 years follow-up</time_frame>
    <description>This study is event driven so there is no set end date for follow-up or analysis. Subjects will be followed until the statistical boundary is crossed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sudden Death in various subgroups</measure>
    <time_frame>Through study completion,estimated average of 2.6 years follow-up</time_frame>
    <description>This study is event driven so there is no set end date for follow-up or analysis. Subjects will be followed until the statistical boundary is crossed.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>S-ICD Inappropriate shock frequency</measure>
    <time_frame>Through study completion,estimated average of 2.6 years follow-up</time_frame>
    <description>Pre-specific tertiary statistical analyses will be descriptive and exploratory</description>
  </other_outcome>
  <other_outcome>
    <measure>S-ICD Inappropriate shock outcomes</measure>
    <time_frame>Through study completion,estimated average of 2.6 years follow-up</time_frame>
    <description>Pre-specific tertiary statistical analyses will be descriptive and exploratory</description>
  </other_outcome>
  <other_outcome>
    <measure>S-ICD treated ventricular arrhythmia frequency</measure>
    <time_frame>Through study completion,estimated average of 2.6 years follow-up</time_frame>
    <description>Pre-specific tertiary statistical analyses will be descriptive and exploratory</description>
  </other_outcome>
  <other_outcome>
    <measure>S-ICD treated ventricular arrhythmia outcomes</measure>
    <time_frame>Through study completion,estimated average of 2.6 years follow-up</time_frame>
    <description>Pre-specific tertiary statistical analyses will be descriptive and exploratory</description>
  </other_outcome>
  <other_outcome>
    <measure>S-ICD device complications</measure>
    <time_frame>Through study completion, estimated average of 2.6 years follow-up</time_frame>
    <description>Pre-specific tertiary statistical analyses will be descriptive and exploratory</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1800</enrollment>
  <condition>Tachycardia</condition>
  <condition>Diabetes Mellitus</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Conventional Medical Therapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This arm of the trial continues with their current conventional medical therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Subcutaneous Implantable Cardioverter Defibrillator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This arm of the trial receives a subcutaneous implantable defibrillator.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Subcutaneous Implantable Cardioverter Defibrillator</intervention_name>
    <description>The S-ICD is an entirely subcutaneous implantable cardioverter defibrillator.</description>
    <arm_group_label>Subcutaneous Implantable Cardioverter Defibrillator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 65 years on date of consent

          -  Diabetes mellitus treated with oral hypoglycemic agents, non-insulin injectable and/or
             insulin for the past 3 calendar months or longer prior to consent date

          -  LV ejection fraction (LVEF) of 36-50% documented by imaging (preferably by MRI or
             echocardiographic methods), within 12 calendar months before consent date and at least
             3 calendar months after most recent Myocardial Infarction (MI), percutaneous coronary
             intervention (PCI) or coronary artery bypass graft (CABG).

          -  One or more clinically documented, enzyme-positive myocardial infarctions, more than 3
             calendar months prior to consent date*. (If enzyme information and clinical
             documentation is not available, there must be a clear evidence of prior silent
             myocardial infarction identified as either new pathologic Q waves on ECG or imaging
             documentation of an infarcted area (left ventricular angiography/ nuclear scan/ MRI)
             Note: MI qualification based on the Universal Definition of MI)

          -  Qualifying 12-lead ECG within 6 calendar months before consent date and at least 3
             calendar months after most recent MI, PCI or CABG. (The qualifying ECG* can be sinus
             rhythm or atrial fibrillation (patients with persistent or permanent atrial
             fibrillation should have a controlled ventricular response &lt;100 bpm on consent date)
             *QRS duration on the qualifying ECG &gt;90 msec)

          -  Passing S-ICD Screening ECG performed per applicable user's manual on or after the
             consent date that identifies one or more qualifying S-ICD sensing vectors

        Exclusion Criteria:

          -  Ejection fraction &gt;50% or &lt;36% within 12 calendar months prior to consent date and at
             least 3 calendar months after the most recent MI, PCI or CABG

          -  Existing guideline based indication for an implantable cardioverter defibrillator
             (ICD), pacemaker, cardiac resynchronization therapy device (CRT), or cardiac
             resynchronization therapy device with defibrillator (CRT-D) therapy

          -  Existing or previously implanted ICD, CRT, CRT-D, or pacemaker device system

          -  Active infection at the time of consent

          -  Contraindication for S-ICD implantation according to the S-ICD pulse generator (PG)
             User's Manual

          -  Hemodialysis and/or peritoneal dialysis at the time of enrollment

          -  New York Heart Association Class IV in the past 3 calendar months prior to or at the
             time of consent date

          -  Coronary artery bypass graft surgery or percutaneous coronary intervention (balloon
             and/or stent angioplasty) within 3 calendar months prior to the consent date

          -  Enzyme-positive myocardial infarction or silent myocardial infarction diagnosed within
             3 calendar months prior to the consent date

          -  Unstable angina with need for outpatient treatment or hospitalization (change/addition
             of anti-anginal medication and/or coronary revascularization), within 3 calendar
             months prior to the consent date

          -  Angiographic evidence of coronary disease in a patient that is a candidate for
             coronary revascularization and is likely to undergo CABG or PCI in the next 3 calendar
             months

          -  High risk for arterial embolism (e.g. presence of mobile left ventricular thrombus)

          -  Hemodynamically significant congenital heart disease, aortic valvular heart disease,
             or amyloid heart disease

          -  Baseline body mass index &gt; 45 kg/m2

          -  On a heart transplant list or likely to undergo heart transplant within one calendar
             year

          -  Presence of any other disease, other than the subject's cardiac disease, that in the
             opinion of the investigator is likely to significantly reduce the patient's likelihood
             of survival for the duration of the trial (e.g. cancer, liver failure).

          -  Unwillingness or inability to cooperate with the protocol

          -  Resides at such a distance from the enrolling site so travel to follow-up visits would
             be unusually difficult

          -  Reversible causes of heart disease (e.g. viral myocarditis or tachycardia induced
             cardiomyopathy)

          -  Participation in other clinical trials (observational registries are allowed with
             approval from the CDC)

          -  Does not anticipate residing in the vicinity of the enrolling site for the duration of
             the trial

          -  Unwillingness to sign the consent for participation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valentina Kutyifa, MD, MSc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester Heart Research Follow-up Program</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valentina Kutyifa, MD, MSc, PhD</last_name>
    <phone>585-275-5391</phone>
    <email>valentina.kutyifa@heart.rochester.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Heart Center Research, LLC.</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Lindsey, RN</last_name>
      <phone>256-519-8143</phone>
      <email>slindsey@theheartcenter.md</email>
    </contact>
    <investigator>
      <last_name>Jay Dinerman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic- Scottsdale</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85259</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vy Nguyen</last_name>
      <phone>480-342-1328</phone>
      <email>nguyen.vy@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Luis Scott, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Glendale Adventist Medical Center</name>
      <address>
        <city>Glendale</city>
        <state>California</state>
        <zip>91206</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janier Valeriano</last_name>
      <phone>818-409-8009</phone>
      <email>javier.valeriano@AH.org</email>
    </contact>
    <investigator>
      <last_name>John McKenzie III, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Ramos, RN</last_name>
      <phone>323-442-7983</phone>
      <email>melissa.ramos@med.usc.edu</email>
    </contact>
    <investigator>
      <last_name>Rahul Doshi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alta Bates Summit Hospital</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manginder (Mag) Sohal, RN</last_name>
      <phone>925-274-2078</phone>
      <email>msohal@stanfordhealthcare.org</email>
    </contact>
    <investigator>
      <last_name>Paul Ludmer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Huntington Hospital</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sadie Seto</last_name>
      <phone>626-397-3764</phone>
      <email>sadie.seto@huntingtonhospital.com</email>
    </contact>
    <investigator>
      <last_name>Mayer Rashtian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paige Smith, RN</last_name>
      <phone>404-686-7992</phone>
      <email>pfsmith@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Mikhael ElChami, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loyola University Medical Center</name>
      <address>
        <city>Maywood</city>
        <state>Illinois</state>
        <zip>60153</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Schoenecker, RN</last_name>
      <phone>708-216-2646</phone>
      <email>nschoenecker@luc.edu</email>
    </contact>
    <investigator>
      <last_name>Smit Vasaiwala , MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Symone Robinson, RN</last_name>
      <phone>319-384-1627</phone>
      <email>symone-robinson@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Michael Giudici, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Louisville</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eleanora Fridell</last_name>
      <phone>502-560-8495</phone>
      <email>eleanora.fridell@louisville.edu</email>
    </contact>
    <investigator>
      <last_name>Brad Sutton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Cardiovascular Specialists</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katy Chalamidas</last_name>
      <phone>318-795-4638</phone>
      <email>kchalamidas@acsdoctors.com</email>
    </contact>
    <investigator>
      <last_name>S. Scott Wiggins, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandy Alexander, RN</last_name>
      <email>salexan4@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Claudio Schuger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Baker, RN</last_name>
      <phone>816-932-0364</phone>
      <email>tkean@saint-lukes.org</email>
    </contact>
    <investigator>
      <last_name>Brian Ramza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nebraska Heart Institute</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Randy Homcolmb, RN</last_name>
      <phone>402-328-3946</phone>
      <email>rholcomb@neheart.com</email>
    </contact>
    <investigator>
      <last_name>Peter Gallagher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catholic Medical Center</name>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <zip>03102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Cornelius</last_name>
      <phone>603-669-0413</phone>
      <email>elizabeth.cornelius@cmc-nh.org</email>
    </contact>
    <investigator>
      <last_name>Jamie Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of Delaware Valley</name>
      <address>
        <city>Haddon Heights</city>
        <state>New Jersey</state>
        <zip>08035</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Coppola</last_name>
      <phone>856-358-8125</phone>
      <email>kcoppola@hearthousenj.com</email>
    </contact>
    <investigator>
      <last_name>George Mark, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health</name>
      <address>
        <city>Manhasset</city>
        <state>New York</state>
        <zip>11030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Lucca-Susana</last_name>
      <email>Mluccasusa@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Stavros Mountantonakis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Strong Memorial / University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Stuart Buttles, RN</last_name>
      <phone>585-341-7764</phone>
      <email>Robin_Stuart@URMC.Rochester.edu</email>
    </contact>
    <investigator>
      <last_name>David Huang, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Carolina Heart and Vascular</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiffany Johnson</last_name>
      <phone>919-784-4031</phone>
      <email>tiffany.johnson@unchealth.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Sameh Mobarek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caitlin McKenna</last_name>
      <phone>614-685-4623</phone>
      <email>caitlin.mckenna@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Raul Weiss, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio Health Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Straughsbaugh, RN</last_name>
      <phone>614-566-1253</phone>
      <email>carol.strausbaugh@ohiohealth.com</email>
    </contact>
    <investigator>
      <last_name>Nagesh Chopra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Promedica Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shirley Schmidt</last_name>
      <phone>419-842-3025</phone>
      <email>shirley.schmidt@promedica.org</email>
    </contact>
    <investigator>
      <last_name>Johan Aasbo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Dreese, RN</last_name>
      <phone>215-481-5807</phone>
      <email>matthew.dreese@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Charles Gottlieb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Phoenixville Hospital</name>
      <address>
        <city>Phoenixville</city>
        <state>Pennsylvania</state>
        <zip>19460</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debra Zlomek, RN</last_name>
      <phone>610-327-4200</phone>
      <phone_ext>184</phone_ext>
      <email>dzlomek@pmsiforlife.com</email>
    </contact>
    <investigator>
      <last_name>Vadim Levin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center - Presbyterian</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Sweeny, RN</last_name>
      <phone>412-864-1420</phone>
      <email>sweenysm@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Samir Saba, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erlanger Medical Center</name>
      <address>
        <city>Chattanooga</city>
        <state>Tennessee</state>
        <zip>37403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Rice</last_name>
      <phone>423-778-3900</phone>
      <email>michelle.rice@erlanger.edu</email>
    </contact>
    <investigator>
      <last_name>Harish Manyam, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas, Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chaitra Muthalgiri, RN</last_name>
      <phone>713-486-1625</phone>
      <email>Chaitra.Mahesh.Muthalgiri@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Khashayar Hematpour, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Judson, RN</last_name>
      <phone>757-388-3876</phone>
      <email>kajudso2@sentara.com</email>
    </contact>
    <investigator>
      <last_name>Allen Ciuffo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Hockman</last_name>
      <phone>804-828-4700</phone>
      <email>melissa.hockman@vcuhealth.org</email>
    </contact>
    <investigator>
      <last_name>Kenneth Ellenbogen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Weber, RN</last_name>
      <phone>206-543-6850</phone>
      <email>rjweber@cardiology.washington.edu</email>
    </contact>
    <investigator>
      <last_name>Jordan Prutkin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PeaceHealth Southwest Medical Center</name>
      <address>
        <city>Vancouver</city>
        <state>Washington</state>
        <zip>98664</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beth Getman</last_name>
      <phone>360-514-2016</phone>
      <email>bgetman@peacehealth.org</email>
    </contact>
    <investigator>
      <last_name>Jonathan Lowy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>HannÃ¶ver</city>
        <state>Niedersachsen</state>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antje Juergens</last_name>
      <email>juergens.antje@mh-hannover.de</email>
    </contact>
    <investigator>
      <last_name>Christian Veltmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unfallkrankenhaus Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12683</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antge Spraner</last_name>
      <email>antje.spranger@ukb.de</email>
    </contact>
    <investigator>
      <last_name>Corrina Lenz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinik Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Scholz</last_name>
      <phone>040941059471</phone>
      <email>su.scholz@uke.de</email>
    </contact>
    <investigator>
      <last_name>Nils Gosau</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kaplan Medical Center</name>
      <address>
        <city>Rechovot</city>
        <zip>76100</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valery Belatsky</last_name>
      <email>valerybe@clalit.org.il</email>
    </contact>
    <investigator>
      <last_name>Moshe Swissa , MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tel Aviv Sourasky Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>6423906</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pnina Azar</last_name>
      <email>pninaa@tlvmc.gov.il</email>
    </contact>
    <investigator>
      <last_name>Raphael Rosso , MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Ospedale Niguarda CA Granda</name>
      <address>
        <city>Milano</city>
        <state>Niguarda</state>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessio Testoni</last_name>
      <phone>39-02-6444-2069</phone>
      <email>alessio.testoni@ospedaleniguarda.it</email>
    </contact>
    <investigator>
      <last_name>Maurizio Lunati , MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMC Utrecht</name>
      <address>
        <city>Utrecht</city>
        <state>CX</state>
        <zip>3584</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Vlaardingerbroek</last_name>
      <phone>310887559432</phone>
      <email>k.vlaardingerbroek@umcutrecht.nl</email>
    </contact>
    <investigator>
      <last_name>Anthonie Tuinenburg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academisch Medisch Centrum</name>
      <address>
        <city>Amsterdam</city>
        <state>NH</state>
        <zip>1105AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linde Vertelman</last_name>
      <email>l.v.vertelman@amc.uva.nl</email>
    </contact>
    <investigator>
      <last_name>Reinoud Knops, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Navarra, Department of Cardiology</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pilar Ara Lucea</last_name>
      <email>paralucea@unav.es</email>
    </contact>
    <investigator>
      <last_name>Ignacio Garcia Bolao , MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>ZÃ¼rich</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ellen Saga</last_name>
      <phone>41442559492</phone>
      <email>ellen.saga@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Jan Steffel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2016</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Subcutaneous</keyword>
  <keyword>Implantable Cardioverter Defibrillator</keyword>
  <keyword>MADIT</keyword>
  <keyword>Diabetes</keyword>
  <keyword>Myocardial Infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

